NEOnatal Multiexposure to Medical Devices Plasticizers: Endocrine Disruption MIXture Effects and Neurodevelopmental Disorders (NEOMIX WP3)

University Hospital, Clermont-Ferrand

Status: Not yet enrolling

Conditions: Neurodevelopmental Disorder (Diagnosis)

Study type: Observational

Funder types: Other

Identifiers

NCT06726824

RNI 2024 BERNARD

Details and patient eligibility

About

The goal of this observational study is to evaluate the neurodevelopment of children from the ARMED NEO cohort through the ASQ3 score.

Dose the multiexposure to medical devices plasticizers during the neonatal intensive care unit stay increases the risk of developing neurodevelopmental disorders ? Patients (their parents) will complète several questionnaires (ASQ3, environnemental survey, EPICES score) during a planned teleconsultation with the research team

Enrollment: 97 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Live patient who participated in the ARMED NEO study, included at the Clermont-Ferrand or Lille hospitals
• Patient whose holders of parental authority have expressed their non-opposition to their participation in the study

Exclusion criteria

• Patient whose guardians have expressed opposition to their participation in the study
• Patient with no French speaking parent
• patient

Trial design

97 participants in 1 patient group

NEOMIX-WP3 cohort

Description:

NEOMIX-WP3 cohort corresponds to the patients incluses in the ARMED NEO cohort (NICU patients) between February 2018 And June 2019. These children are now between 6 And 7. Their parents will be asked by validated questionnaries to evaluate the Neurodevelopmental status And eventual risk factors since they got back home after NICU stay